A study using data from the 2022 Behavioral Risk Factor Surveillance System (BRFSS) examined the prevalence and factors associated with long COVID symptoms among U.S. adults. Over one in five adults who had previously been diagnosed with COVID-19 reported symptoms consistent with long COVID, with 21.8% of those surveyed experiencing long COVID. The most common symptoms were tiredness or fatigue (26.2%), difficulty breathing or shortness of breath (18.9%), and loss of taste or smell (17.0%). Long COVID was more common among younger adults, women, American Indian or Alaska Native, other/multi-racial groups, smokers, and individuals with disabilities, depression, or overweight/obesity. The prevalence of long COVID was higher among unvaccinated adults (25.6%) compared to vaccinated adults (21.6%). The study found that vaccination was associated with a lower prevalence of long COVID, highlighting the importance of vaccination in preventing long-term effects of COVID-19. Factors such as age, sex, race/ethnicity, income, health insurance, and health conditions were associated with the likelihood of experiencing long COVID. Additionally, differences in long COVID symptoms were observed across various demographic and health-related groups. For example, younger adults were less likely to experience tiredness or fatigue but more likely to experience loss of taste or smell. Women were less likely to experience difficulty breathing but more likely to experience difficulty thinking or concentrating. The study also found that individuals with overweight or obesity were more likely to experience difficulty breathing but less likely to experience loss of taste or smell. Current smokers were more likely to experience joint or muscle pain. Individuals with disabilities were more likely to experience difficulty breathing and difficulty thinking or concentrating but less likely to experience loss of taste or smell. Those with depression were more likely to experience difficulty thinking or concentrating but less likely to experience loss of taste or smell. The study underscores the importance of vaccination in preventing long-term effects of COVID-19 and highlights the need for targeted interventions to address disparities in long COVID outcomes. It also emphasizes the importance of early testing and treatment to minimize the potential for severe health consequences. The findings suggest that vaccination can help advance health equity and protect those most vulnerable to long-term health consequences of COVID-19.A study using data from the 2022 Behavioral Risk Factor Surveillance System (BRFSS) examined the prevalence and factors associated with long COVID symptoms among U.S. adults. Over one in five adults who had previously been diagnosed with COVID-19 reported symptoms consistent with long COVID, with 21.8% of those surveyed experiencing long COVID. The most common symptoms were tiredness or fatigue (26.2%), difficulty breathing or shortness of breath (18.9%), and loss of taste or smell (17.0%). Long COVID was more common among younger adults, women, American Indian or Alaska Native, other/multi-racial groups, smokers, and individuals with disabilities, depression, or overweight/obesity. The prevalence of long COVID was higher among unvaccinated adults (25.6%) compared to vaccinated adults (21.6%). The study found that vaccination was associated with a lower prevalence of long COVID, highlighting the importance of vaccination in preventing long-term effects of COVID-19. Factors such as age, sex, race/ethnicity, income, health insurance, and health conditions were associated with the likelihood of experiencing long COVID. Additionally, differences in long COVID symptoms were observed across various demographic and health-related groups. For example, younger adults were less likely to experience tiredness or fatigue but more likely to experience loss of taste or smell. Women were less likely to experience difficulty breathing but more likely to experience difficulty thinking or concentrating. The study also found that individuals with overweight or obesity were more likely to experience difficulty breathing but less likely to experience loss of taste or smell. Current smokers were more likely to experience joint or muscle pain. Individuals with disabilities were more likely to experience difficulty breathing and difficulty thinking or concentrating but less likely to experience loss of taste or smell. Those with depression were more likely to experience difficulty thinking or concentrating but less likely to experience loss of taste or smell. The study underscores the importance of vaccination in preventing long-term effects of COVID-19 and highlights the need for targeted interventions to address disparities in long COVID outcomes. It also emphasizes the importance of early testing and treatment to minimize the potential for severe health consequences. The findings suggest that vaccination can help advance health equity and protect those most vulnerable to long-term health consequences of COVID-19.